Crossmark

Integrated single-cell and bulk sequencing analyses with experimental validation identify the prognostic and immunological implications of CD226 in pan-cancer

Crossref DOI link: https://doi.org/10.1007/s00432-023-05268-y

Published Online: 2023-08-14

Published Print: 2023-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ma, Peng

Sun, Weili
License Information

Text and Data Mining valid from 2023-08-14

Version of Record valid from 2023-08-14
More Information

Article History

Received: 31 May 2023

Accepted: 9 August 2023

First Online: 14 August 2023

Declarations

:

: The authors declare no potential conflicts of interest.

: The animal study protocol was approved by the Ethics Committee of IRCM (2019-03 HG).

: Not applicable.

: Not applicable.

Document is current

Any future updates will be listed below